secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spyre Therapeutics, Inc. (SYRE)
CIK:        0001636282
Form:       8-K
Filed at:   2023-10-05T23:59:59+00:00
Accession:  0001193125-23-251664
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Aeglea amends Paragon agreement, commits to annual 1% option grants for 2023-2024
--------------------------------------------------------------------------------

- Annual option grant of 1% of outstanding Aeglea common stock (fully-diluted) to Parapyre for calendar years 2023 and 2024.
- Grant date set to last business day of each applicable year; options vest immediately and have a 10-year term.
- Paragon and Parapyre each hold less than 5% of Aeglea's capital stock; Fairmount (>5% holder) controls Paragon's board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636282/000119312523251664/0001193125-23-251664-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636282/000119312523251664/d554720d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-251664

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer